Autoimmune diabetes in HIV-infected patients on highly active antiretroviral therapy

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 8, 2010, Pages 4056-4060

  Takarabe, Daisuke ^a   Rokukawa, Yuka ^a   Takahashi, Yoshihiko ^a   Goto, Atsushi ^a   Takaichi, Maki ^a   Okamoto, Masahide ^a   Tsujimoto, Tetsuro ^a   Noto, Hiroshi ^a   Kishimoto, Miyako ^a   Kaburagi, Yasushi ^a   Yasuda, Kazuki ^a   Yamamoto Honda, Ritsuko ^a   Tsukada, Kunihisa ^a   Honda, Miwako ^a   Teruya, Katsuji ^a   Kajio, Hiroshi ^a   Kikuchi, Yoshimi ^a   Oka, Shinichi ^a   Noda, Mitsuhiko ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; AUTOANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; INSULIN; SULFONYLUREA;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CASE REPORT; CD4 LYMPHOCYTE COUNT; CONVALESCENCE; ETHICS; FEMALE; GLYCEMIC CONTROL; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INSULIN TREATMENT; JAPANESE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 77955352062     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0055     Document Type: Article

References (20)

1. Alberti KG, Zimmet PZ 1998 Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553
2. Florescu D, Kotler DP 2007 Insulin resistance, glucose intolerance and diabetes mellitus in HIV-infected patients. Antivir Ther 12:149-162
3. Aboud M, Elgalib A, Kulasegaram R, Peters B 2007 Insulin resistance and HIV infection: a review. Int J Clin Pract 61:463-472
4. Murdoch DM, Venter WD, Van Rie A, Feldman C 2007 Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options. AIDS Res Ther 4:9
5. Zandman-Goddard G, Shoenfeld Y 2002 HIV and autoimmunity. Autoimmun Rev 1:329-337
6. Calabrese LH, Kirchner E, Shrestha R 2005 Rheumatic complications of human immunodeficiency virus infection in the era of highly active antiretroviral therapy: emergence of a new syndrome of immune reconstitution and changing patterns of disease. Semin Arthritis Rheum 35:166-174
7. Knysz B, Bolanowski M, Klimczak M, Gladysz A, Zwolinska K 2006 Graves' disease as an immune reconstitution syndrome in an HIV-1-positive patient commencing effective antiretroviral therapy: case report and literature review. Viral Immunol 19:102-107
8. Chen F, Day SL, Metcalfe RA, Sethi G, Kapembwa MS, Brook MG, Churchill D, de Ruiter A, Robinson S, Lacey CJ, Weetman AP 2005 Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advanced human immunodeficiency virus (HIV) disease. Medicine (Baltimore) 84:98-106
9. Jubault V, Penfornis A, Schillo F, Hoen B, Izembart M, Timsit J, Kazatchkine MD, Gilquin J, Viard JP 2000 Sequential occurrence of thyroid autoantibodies and Graves' disease after immune restoration in severely immunocompromised human immunodeficiency virus-1-infected patients. J Clin Endocrinol Metab 85:4254-4257
10. French MA, Lewin SR, Dykstra C, Krueger R, Price P, Leedman PJ 2004 Graves' disease during immune reconstitution after highly active antiretroviral therapy for HIV infection: evidence of thymic dysfunction. AIDS Res Hum Retroviruses 20:157-162
11. Vos F, Pieters G, Keuter M, van der Ven A 2006 Graves' disease during immune reconstitution in HIV-infected patients treated with HAART. Scand J Infect Dis 38:124-126
12. Betterle C, Dal Pra C, Mantero F, Zanchetta R 2002 Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 23:327-364
13. Kawabata Y, Ikegami H, Kawaguchi Y, Fujisawa T, Shintani M, Ono M, Nishino M, Uchigata Y, Lee I, Ogata T 2002 Asian-specific HLA haplotypes reveal heterogeneity of the contribution of HLA-DR and -DQ haplotypes to susceptibility to type 1 diabetes. Diabetes 51:545-551
14. Verge CF, Stenger D, Bonifacio E, Colman PG, Pilcher C, Bingley PJ, Eisenbarth GS 1998 Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes 47:1857-1866
15. Sera Y, Kawasaki E, Abiru N, Ozaki M, Abe T, Takino H, Kondo H, Yamasaki H, Yamaguchi Y, Akazawa S, Nagataki S, Uchigata Y, Matsuura N, Eguchi K 1999 Autoantibodies to multiple islet autoantigens in patients with abrupt onset type 1 diabetes and diabetes diagnosed with urinary glucose screening. J Autoimmun 13:257-265
16. Zimmet PZ, Tuomi T, Mackay IR, Rowley MJ, Knowles W, Cohen M, Lang DA 1994 Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 11:299-303
17. Kobayashi T, Tamemoto K, Nakanishi K, Kato N, Okubo M, Kajio H, Sugimoto T, Murase T, Koska K 1993 Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care 16:780-788
18. Hampe CS, Nalini R, Maldonado MR, Hall TR, Garza G, Iyer D, Balasubramanyam A 2007 Association of amino-terminal-specific antiglutamate decarboxylase (GAD65) autoantibodies with β-cell functional reserve and a milder clinical phenotype in patients with GAD65 antibodies and ketosis-prone diabetes mellitus. J Clin Endocrinol Metab 92:462-467
19. Hyppönen E, Virtanen SM, Kenward MG, Knip M, Akerblom HK 2000 Obesity, increased linear growth, and risk of type 1 diabetes in children. Diabetes Care 23:1755-1760
20. Jun HS, Yoon JW 2003 A new look at viruses in type 1 diabetes. Diabetes Metab Res Rev 19:8-31